Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients.

BRCA1/2 BRIP1 PALB2 RAD51C/D ovarian cancer survival

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
28 Apr 2023
Historique:
received: 28 03 2023
revised: 24 04 2023
accepted: 26 04 2023
medline: 13 5 2023
pubmed: 13 5 2023
entrez: 13 5 2023
Statut: epublish

Résumé

Data on deleterious variants in genes other than

Identifiants

pubmed: 37174000
pii: cancers15092534
doi: 10.3390/cancers15092534
pmc: PMC10177155
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Oncol. 2012 Jul 20;30(21):2654-63
pubmed: 22711857
Gynecol Oncol. 2016 Jan;140(1):42-7
pubmed: 26556769
Ann Oncol. 2023 Jan;34(1):33-47
pubmed: 36307055
JAMA. 2012 Jan 25;307(4):382-90
pubmed: 22274685
J Clin Oncol. 2020 Apr 10;38(11):1222-1245
pubmed: 31986064
Gynecol Oncol. 2018 Dec;151(3):481-488
pubmed: 30322717
Chin Clin Oncol. 2020 Aug;9(4):47
pubmed: 32648448
Cancers (Basel). 2022 Apr 29;14(9):
pubmed: 35565359
N Engl J Med. 2019 Dec 19;381(25):2416-2428
pubmed: 31851799
J Clin Oncol. 2020 Dec 20;38(36):4274-4282
pubmed: 33119476
Geburtshilfe Frauenheilkd. 2020 Sep;80(9):932-940
pubmed: 32905297
J Clin Oncol. 2020 Mar 1;38(7):674-685
pubmed: 31841383
N Engl J Med. 2019 Dec 19;381(25):2391-2402
pubmed: 31562799
Cancer Med. 2018 Apr;7(4):1349-1358
pubmed: 29522266
Ann Oncol. 2019 May 1;30(5):672-705
pubmed: 31046081
J Clin Oncol. 2015 Nov 20;33(33):3858-65
pubmed: 26282658
Gynecol Oncol. 2016 Mar;140(3):443-9
pubmed: 26740259
J Natl Compr Canc Netw. 2017 Jan;15(1):9-20
pubmed: 28040716
Clin Cancer Res. 2014 Feb 1;20(3):764-75
pubmed: 24240112
J Obstet Gynaecol Res. 2019 Nov;45(11):2267-2274
pubmed: 31411802
JAMA Oncol. 2016 Apr;2(4):482-90
pubmed: 26720728
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
Gynecol Oncol. 2021 Dec;163(3):569-577
pubmed: 34565600
Int J Gynecol Cancer. 2019 Jan;29(1):166-173
pubmed: 30640700
J Natl Cancer Inst. 2020 Dec 14;112(12):1242-1250
pubmed: 32107557
N Engl J Med. 2015 Oct 29;373(18):1697-708
pubmed: 26510020
PLoS One. 2017 Oct 20;12(10):e0186043
pubmed: 29053726
J Natl Cancer Inst. 2015 Aug 27;107(11):
pubmed: 26315354

Auteurs

Majdi Imterat (M)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.
Department of Gynaecologic Oncology, Hadassah Medical Centers, Faculty of Medicine, Hebrew University of Jerusalem, Kalman Ya'Akov Man St., Jerusalem 91905, Israel.

Philipp Harter (P)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.

Kerstin Rhiem (K)

Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, 50931 Cologne, Germany.

Florian Heitz (F)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.
Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Stephanie Schneider (S)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.

Nicole Concin (N)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.

Malak Moubarak (M)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.

Julia Welz (J)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.

Vasileios Vrentas (V)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.

Alexander Traut (A)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.

Eric Hahnen (E)

Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, 50931 Cologne, Germany.

Rita Schmutzler (R)

Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, 50931 Cologne, Germany.

Andreas du Bois (A)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.

Beyhan Ataseven (B)

Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), 45136 Essen, Germany.
Academic Department of Gynecology, Gynecologic Oncology and Obstetrics, Klinikum Lippe, Medical School, University Medical Center East Westphalia-Lippe, Bielefeld University, 33615 Bielefeld, Germany.

Classifications MeSH